← back to search

David Greenwood

UCL Biomedical Research Centre · GB
Area of research
Infectious Diseases · Pharmacology
Research interest
Research interests include SARS-CoV-2 and COVID-19 Research, Antibiotics Pharmacokinetics and Efficacy, Antibiotic Resistance in Bacteria, and vaccines and immunoinformatics approaches.
h-index
14
citations
1,761
works
68
NIH funding
—
primary concept
—
email
✉ Find email ↗

Recent publications

COVID-19 in non-hospitalised adults caused by either SARS-CoV-2 sub-variants Omicron BA.1, BA.2, BA.4/5 or Delta associates with similar illness duration, symptom severity and viral kinetics, irrespective of vaccination history
PLoS ONE 2024cited by 11position: middledoi
Real-time estimation of immunological responses against emerging SARS-CoV-2 variants in the UK: a mathematical modelling study
The Lancet Infectious Diseases 2024cited by 7position: middledoi
Dietary fibre intake and risk of cardiovascular disease: systematic review and meta-analysis
BMJ 2013cited by 747position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Charlotte Evans · University of Leeds1 papers (2013–2013)Camilla Nykjaer · University of Leeds1 papers (2013–2013)Chris P Gale · Imperial College London1 papers (2013–2013)Janet Cade · University of Leeds1 papers (2013–2013)Diane Threapleton · University of Leeds1 papers (2013–2013)V. J. Burley · University of Leeds1 papers (2013–2013)Christine Cleghorn · University of Auckland1 papers (2013–2013)